While the life cycles of hepatitis viruses (A, B, C, D, and E) have been modestly characterized, recent intensive studies have provided new insights into their progression. Because these viruses "hijack" the membrane trafficking of the host cell machinery during replicative propagation, it is essential to determine and understand these specific cellular pathways. Hepatitis B virus (HBV) and hepatitis C virus (HCV) are well known as leading causes of liver cirrhosis and hepatocellular carcinoma. While substantial inroads toward treating HCV-infected patients have recently been made, patients with HBV continue to require lifelong treatment, which makes a thorough understanding of the HBV life cycle essential. Importantly, these viruses have been observed to "hijack" the secretory and endocytic membrane trafficking machineries of the hepatocyte. These cellular membrane trafficking mechanisms can include the canonical clathrin-mediated endocytic process that internalizes virus through cell surface receptors. While these receptors are encoded by the host genome for normal hepatocellular functions, they also exhibit virus-specific recognition. Most of these viruses represent a substantial worldwide health problem as acute infection can lead to fulminant hepatitis, requiring liver transplantation. Even more problematic is the inability of a patient's immune response to eliminate or "clear" the virus following acute infection of HBV, HCV, and HDV. This can lead to recurrent and persistent infections, potentially resulting in hepatocellular carcinoma.
I t is well established that viruses usurp hepatocellular trafficking processes throughout propagation.
This involves viral utilization of the transport/ transcription/translation machinery of the hepatocyte for cell entry and subsequent packaging, assembly, transport, and release into the extracellular space. The hepatitis viruses have apparently made optimal use of these cellular pathways over time. To date, five hepatitis viruses (hepatitis A virus [HAV] , hepatitis B virus [HBV] , hepatitis C virus [HCV] , hepatitis D virus [HDV] , and hepatitis E virus [HEV] ) have been identified and infect hepatocytes almost exclusively. Most of these viruses represent a substantial worldwide health problem as acute infection can lead to fulminant hepatitis, requiring liver transplantation. Even more problematic is the inability of a patient's immune response to eliminate or "clear" the virus following acute infection of HBV, HCV, and HDV. This can lead to recurrent and persistent infections, potentially resulting in hepatocellular carcinoma.
As hepatocytes are responsible for a number of physiological processes including uptake, metabolism/ processing, and release of proteins, lipids, and carbohydrates to and from the sinusoidal space, the membrane/ vesicle trafficking of the hepatocyte is particularly complicated. (1) This transport of cellular constituents is supported by a vesicular transport system comprised of different coats, adaptors, and cytoskeletal elements superimposed upon an intricate signaling and targeting system. The end result is a tenuous but accurate vesiculation, transport, and fusion of different-sized membrane containers to and from desired locations. (2) and late endosomal pathways yet appear able to avoid degradation in the terminal lysosomal compartments of the hepatocyte. Further, recent studies have demonstrated that these viruses use endosomal pathways such as multivesicular bodies (MVBs) in the envelopment and release steps. How these viruses manipulate these pathways to optimize infection is unclear and needs to be determined. In this review, we provide specific insights into the hepatocyte membrane trafficking processes that are usurped by this important group of pathogenic viruses.
Background and Structure of Hepatitis Viruses

HBV
HBV is a prototype of the Hepadnaviridae family with a circular genome comprised of partially double-stranded DNA 3.2 kb in length (Fig. 1A) . Five viral mRNAs (two different 3.5 kb, 2.4 kb, 2.1 kb, and 0.7 kb) are transcribed from covalently closed circular DNA in the nucleus, and seven different viral proteins are translated. The genome has four partly overlapping open reading frames (ORFs): the pre-S/S gene encoding for three HBV surface proteins (large, medium, and small), the pre-C/C gene encoding for the HBV e protein and the core protein, the P gene encoding for the polymerase protein, and the X gene encoding for the HBV x protein (HBx). Of the seven proteins, the virion, which is termed the "Dane particle," does not contain HBV e protein and HBx. The virion is spherical and 42 nm in diameter and has an outer membrane that consists of large, medium, and small HBV surface proteins and an inner nucleocapsid containing the genomic DNA and the polymerase protein. These surface proteins are inserted into a lipid bilayer derived from host cells.
HDV
HDV is only the virus in the genus Deltavirus, and its family has yet to be assigned. The HDV genome is a circular, single-stranded, negative-sense RNA, which is 1.7 kb in length (Fig. 1B) . This virion is spherical and only 36 nm in diameter: the core-like structure containing HDV RNA complexed with hepatitis delta antigen is surrounded by HBV envelope proteins. There are two forms of hepatitis delta antigen: large and small. Small hepatitis delta antigen is not required to form particles but increases packaging efficiency.
HCV
HCV is a member of the Flaviviridae family, and its genome is a single positive-stranded RNA which is 9.6 kb in length (Fig. 1C) . The HCV genome is a translated into a polyprotein that is processed into 10 viral proteins by host and viral proteases. Of the 10 HCV proteins, three are structural (core, E1, and E2) and seven are nonstructural proteins (p7, NS2, NS3, NS4A, NS4B, NS5A, and NS5B) that together form a particle of 50-80 nm diameter. The nucleocapsid consists of the HCV genome and a surrounding core protein that is covered with the envelope consisting of E1 and E2 glycoproteins and lipid membrane derived from the hepatocyte.
HaV
HAV is classified as the genus Hepatovirus within the family Picornaviridae. The HAV genome is a single-stranded, positive-sense RNA virus of approximately 7.5 kb in size (Fig. 1D ). HAV has a single aRtICle INFoRMatIoN:
FIg. 1. Genomic structures of the hepatitis viruses. Bold type indicates genes coding membrane proteins, and italic type indicates genes coding capsid proteins. (A) Genomic structure of HBV. The 3.2-kb DNA genome is circular, and partially double-stranded. There are four partly overlapping ORFs (preS/S, preC/C, P, and X) and five different mRNAs (two kinds of 3.5 kb, 2.4 kb, 2.1 kb, and 0. ORF of 2,227 amino acids organized into four structural proteins (VP4, VP2, VP3, and VP1pX) and six nonstructural proteins, lacking envelope proteins. The HAV RNA genome is packaged within an icosahedral protein capsid composed of three major structural proteins, VP1, VP2, and VP3. pX, which is an 8-kDa carboxy-terminal extension of VP1, is required for the assembly of the capsid proteins.
HeV
HEV, which is classified as the genus Hepevirus in the family Hepeviridae, is a single-stranded, positive-sense RNA virus with a 7.2-kb genome (Fig. 1E) . The HBV genome consists of a 5′ untranslated region including a 7-methylguanine cap, followed by three ORFs (ORF1, ORF2, and ORF3), and then a poly(A) stretch at the 3′ untranslated region terminal. As HEV particles are shed in the feces of infected individuals and lack a lipid envelope, HEV had been considered a nonenveloped virus. The HEV replication cycle was poorly understood because of lack of efficient propagation in cultured cells or infectious animal models. However, an efficient cell-culture system for HEV study was reported in 2007, and some in vitro studies have reported interesting findings. (3) 
attaCHMeNt oF HepatItIS VIRuSeS to tHe plaSMa MeMBRaNe
During the initial stages of host cell infection many viruses attach and move laterally along the cell surface prior to endocytic entry (Fig. 2) . (4) Similarly, HBV entry is considered to be a multistep process initiated by viral attachment to the cell surface through an interaction between the pre-S domain and heparan sulfate proteoglycans (HSPGs). This tenuous interaction is enhanced by binding to the sodium taurocholate cotransporting polypeptide (NTCP), which has been identified as a functional receptor of HBV and hepatitis delta virus (HDV), which possesses the same envelope as HBV. (5) Recently, an interesting mechanism was reported regarding the interaction between HBV and HSPGs in which the HBV particles are released in an inactive form that does not bind to HSPGs and is then converted to an active form that spontaneously exposes the pre-S domain to the surface. (6) In addition, there is a species specificity to these interactions as the human NTCP supports infection while a mouse NTCP does not. NTCP interacts with the pre-S1 domain of large hepatitis B surface protein, while overexpression confers HBV susceptibility on the otherwise nonsusceptible hepatoma cell lines HuH7 and HepG2. A peptide derived from a consensus 47-amino acid stretch in the N terminus of large hepatitis B surface protein inhibits the interaction between NTCP and large hepatitis B surface protein, (7) while the inhibition of HBV spreading from infected hepatocytes was demonstrated in a humanized mouse model. Moreover, cyclosporine A and its analogs inhibit the binding of NTCP and large hepatitis B surface protein, (8) making them promising agents to treat HBV infection. Table 1 summarizes the important molecules and organelles in membrane trafficking machineries used by HBV as well as other hepatitis viruses in each step.
The initial attachment of HCV particles to hepatocytes may be mediated by the HSPG syndecan-1, syndecan-4, or scavenger receptor B1. Apolipoproteins such as apoA1, apoB100, apoB48, apoC1-3, and apoE are present on HCV particles (9) ; are reported to be involved in the initial contact. (10) Some researchers have hypothesized that the interaction with scavenger receptor B1 helps the dissociation of lipoproteins on HCV particles and the exposure of the cluster of differentiation 81 (CD81)-binding sites on E2 glycoprotein. (10) The low-density lipoprotein receptor has been reported to play a role in HCV entry, but a recent surprising study reported that the physiological function of the low-density lipoprotein receptor is important for the replication of the HCV genome and not essential for infectious HCV entry. (11) The HCV particles interact with several cellular entry factors after the initial attachment. These factors include tetraspanin CD81 (12) and tight-junction proteins claudin-1 (13) and occludin. (14) CD81, whose major extracellular loop binds to HCV E2 protein, (12) is the first reported factor and is considered a key molecule. Claudin-1 forms a complex with CD81, and this interaction is thought to be activated by epidermal growth factor receptor through HRas activation. (15) The requirement of occludin at a late entry step has been shown clearly, but its detailed role remains unknown. Additional entry factors, Niemann-Pick C1-like 1 and transferrin receptor 1 have also been reported.
The attachment factor of HAV and HEV remains largely unknown. So far, two candidates of the HAV receptor have been reported: T cell immunoglobulin and mucin-containing domain protein 1 (also known as HAV cellular receptor 1) and an asialoglycoprotein receptor. T cell immunoglobulin and mucin-containing domain protein 1 is not essential for the entry but facilitates uptake by binding phosphatidylserine residues on its surface. (16) Also, an HEV capsid protein encoded by ORF2 concentrates at the surface of target cells through HSPG, specifically syndecans that have been reported to be attachment factors. Asialoglycoprotein receptor has been reported to interact with this ORF2 protein and is considered to facilitate the binding of HEV to cells.
eNDoCytIC INteRNalIZatIoN oF HepatItIS VIRuSeS
After docking to the cell surface, hepatitis viruses are internalized by endocytosis (Fig. 2) . Remarkably, the precise endocytic mechanisms used by hepatitis viruses remain unclear as there are several modes of endocytosis, including clathrin-mediated, caveolae/ caveolin1-dependent, a clathrin-independent carrier interleukin-2 receptor pathway, phagocytosis, macropinocytosis, circular dorsal ruffles, and entosis. Recently, it was reported that the entry of HBV is caveolin-1-dependent (17) ; but more recently, another group described that clathrin is required for the entry. This discrepancy may be due to differences in the cell lines used as the former study used HepaRG cells, derived from a liver tumor of a hepatocellular carcinoma patient, while the latter study implemented a line derived from primary human hepatocytes, HuS-E/2 cells. (18) As HepG2 and Huh7 cells, which express very low levels of caveolin-1, support HBV infection after the expression of NTCP, (5) the role of this coat protein in HBV internalization requires further study.
Following endocytic internalization, HBV is believed to undergo uncoating prior to entry of its genome into the nucleus (Fig. 2) . The mechanisms supporting this important step are unclear, although the small guanosine triphosphatases Rab5 and Rab7 (19) have been implicated. Rab proteins act as molecular switches in the formation, transport, tethering, and fusion of vesicles for regulating the trafficking between organelles. Rab5 mediates the fusion of endocytic vesicles to form early endosomes, and Rab7 plays a key role in the endosomal maturation, facilitating the fusion of late endosomes and lysosomes. These early endosomes become more acidic during maturation, while Rab5 is replaced by Rab7, along with the acquisition of a different spectrum of phosphoinositides, on the limiting membrane. Endosomal maturation is likely required for nuclear viral entry, but it remains unclear how the HBV escapes from lysosomal degradation to transport its genome as a core particle to the nucleus. The HBV genome that is transported to the nucleus forms covalently closed circular DNA, which is a stable template for viral mRNAs. Because the envelope of HDV consists of large, middle, and small hepatitis B surface proteins, HDV might use the same membrane trafficking machineries as HBV, at least partially. HDV, as well as HBV, uses NTCP as a receptor. 5 Therefore, HDV may enter hepatocytes by the same route as HBV. After HDV enters the cells, the viral particle might be uncoated and the genome might be released into the cytosol; but the detailed mechanism remains unclear.
After the interaction of HCV and several entry factors, the viral particles are internalized through clathrin and dynamin-dependent endocytosis. Then, the particles are transported to Rab5A-positive early endosomes, 20 where pH-dependent membrane fusion is believed to occur. The HCV genome appears to be released into the cytosol and translated into a viral polyprotein.
Neither the mode of endocytosis nor the postendocytosis pathway of HAV have been determined, although viral entry may occur through the basolateral membrane. HEV entry requires dynamin 2, clathrin, membrane cholesterol, and actin; and it is indicated that HEV enters the cells through receptor-dependent, clathrin-mediated endocytosis. Following the entry of HEV, heat shock protein 90 mediates the intracellular trafficking of viral capsid in the early stage. HEV initially traffics to Rab5-positive compartments en route to acidic lysosomal compartments. Recently, it was shown that enveloped virus and nonenveloped virus use distinct entry routes as for both HAV and HEV. Enveloped HEV enters cells in a manner dependent on clathrin, Rab5, and Rab7; and acidification is required for the infection of enveloped HEV but not for that of nonenveloped HEV. Also, enveloped HAV is blocked by chloroquine, but nonenveloped HAV is not. 21 Collectively, hepatitis viruses become attached to hepatocytes through interaction with cellular proteins enriched in hepatocytes and are endocytosed mainly through clathrin-mediated endocytosis. This mode of endocytosis is commonly used by viruses of small or intermediate size. 4 However, some viruses can use more than one pathway, 4 and the results should be interpreted carefully. Following internalization, pH-dependent membrane fusion occurs, leading to endosomal/lysosomal release into the cytosol of the viral RNA genomes. Studies of duck HBV have suggested that a low pH is not required for the infection. 22 It is particularly interesting that these viruses are able to avoid degradation by the lysosome through a presently undefined mechanism. Furthermore, the transport pathway used for genomic transfer from late endosome to the nucleus that is specific to HBV has not been determined.
NaSCeNt VIRal pRoteINS CoMINg FRoM tHe eNDoplaSMIC RetICuluM aND golgI
As the HBV envelope proteins do not possess a signal sequence and are translated on free polysomes, many particles secreted from infected cells are noninfectious subviral particles (SVPs) in addition to the infectious virion that aids in infection. This is a unique characteristic of Hepadnaviridae. Because the secretions of these noncapsid proteins are robust, they may work as decoys to "compete" with the host immune system against HBV 23 and play important roles in the development of persistent infection. In fact, secreted SVPs have been reported to reach remarkably high levels, 10,000 times more than the virion proteins. While some have speculated that the virions and SVPs use a common secretory pathway, recent studies have suggested that the pathways are different. 24 SVPs exhibit a structural organization as an octahedral sphere of about 20 nm in diameter or as a filament with the same diameter but of variable length. Recent studies based on transmission electron microscopy (TEM) have suggested that small HBV surface protein self-assembles initially in a filamentous form within a perinuclear endoplasmic reticulum (ER) compartment. 23 These filaments are folded, bridged into crystal-like structures, and then transported to the rough ER-Golgi intermediate compartment independently from microtubules. 25 Consequently, the filaments are unpacked before conversion into spherical particles for secretion. While it is assumed that this export from the ER-Golgi intermediate compartment uses a constitutive cellular secretory route, the actual pathway remains unknown. Among three envelope proteins of HBV, the large HBV surface protein containing a pre-S1 domain can be retained in the ER by a series of N-terminal amino acids. Large HBV surface proteins is essential for the biogenesis of infectious virion, and it had been thought for a long time that the HBV envelope is derived from the ER.
In contrast to HBV, the viral genomes of RNA hepatitis viruses that are released from the endosomes are translated into polyproteins in the ER (Fig. 2) . The polyproteins are cleaved into individual functional proteins (Fig. 1) by host proteases or viral proteases. For instance, HEV genomic RNA is first translated into the ORF1 polyprotein, which contains the methyltransferase, papain-like cysteine protease, RNA helicase, and RNA-dependent RNA polymerase. Using these enzymes, this virus replicates its positive-sense genomic RNA to a negative-sense transcript that subsequently serves as a template of the subgenomic positive-sense RNAs coding ORF2 and ORF3 proteins. The ORF2 protein packages genomic RNA into new capsid. Recent studies have suggested that the HEV and HAV capsids are released through the MVBs (mentioned later), although this transport pathway of capsid to MVBs has not been determined.
Characteristically, HCV extensively remodels intracellular membranes to construct a "membranous web" in order to increase the local concentration of factors used for efficient RNA replication and spatial coordination of different steps of the replication cycle as well as protecting viral components from antiviral defenses. This membranous web consists of double membrane vesicles with an average diameter of 150 nm that are believed to be derived from the ER. Furthermore, this membranous web also contains lipid droplets that are thought to coordinate RNA synthesis and the morphogenesis of HCV particles. 26 Core and NS5A proteins are found on lipid droplets and are considered to regulate the virion assembly together with other nonstructural proteins on the ER membrane. Double-stranded RNA was found to surround lipid droplets, suggesting that RNA replication takes place there. Further, it is interesting that the lipid droplet-associated proteins Rab18 27 and tail-interacting protein 47 28 have been reported to be associated with viral RNA replication. Following the assembly of HCV virions at the ER, 29 vesicle-associated membrane protein 1 and vesicle soluble N-ethylmaleimide-sensitive factor attachment receptor, located on secretory vesicles at the trans-Golgi network, appear to facilitate the fusion of the vesicles and the plasma membrane and are required for the egress of HCV. 29 Importantly, depletion of a recycling endosomal Rab (Rab11), increased retention of the HCV core protein in the Golgi, suggesting the involvement of this compartment in the release of HCV.
29
MVBS aND late eNDoSoMeS aS eSSeNtIal FoR VIRal MatuRatIoN aND ReleaSe
MVBs are late endocytic organelles that contain numerous intraluminal vesicles (ILVs). The budding of these ILVs into the MVB lumen is topologically equal to the budding at the plasma membrane. While multiple viruses, 21, 30 including HBV, use the MVB machinery (Fig. 2) , it remains undetermined how the viral envelope proteins are transported onto MVBs. Figure 3 depicts published images of confocal microscopy or TEM, showing that proteins or particles of hepatitis viruses are found in MVBs. [30] [31] [32] The multisubunit membrane remodeling complex termed endosomal sorting complexes required for transport machinery (ESCRT) catalyzes the biogenesis of ILVs. The ESCRT-III complex has membrane fission activity while the upstream ESCRT-I and ESCRT-II complexes coordinate the fission with the forming and sorting of cargo.
Recently, it was demonstrated that the morphology of MVBs in HBV-expressing cells is changed dramatically, leading to the formation of an excessive number of tubules extending from the surfaces of the MVBs and of the autophagosomes. 32 This process is dependent upon Rab7, which is known to act as a molecular switch promoting the fusion between MVBs/ autophagosomes and lysosomes. Importantly, small interfering RNA-mediated knockdown of Rab7 and treatment with a lysosome inhibitor increased HBV secretion, indicating that Rab7 facilitates the degradation of HBV in lysosomes. Interestingly, not just the intact HBV but specific components of this virus, including the precore/HBV e protein, activate Rab7. These findings showed that HBV infection induces tubulation from MVB/autophagosome and promotes fusion with lysosomes to regulate its own secretion. It was suggested that HBV uses this regulation system to develop persistent infection. More recently, it was reported that not only the HBV Dane particles but also subviral filaments that contain substantially more large HBV surface protein are released by MVBs, differing from SVPs. Thus, large HBV surface proteins may be transported preferably from the ER to MVBs by an unclear mechanism.
Recent findings have suggested that exosomes could contain HCV particles or its genome to support the infective transmission between hepatocytes. 33 Further, a recent study using an MVB inhibitor found that at least a fraction of mature HCV particles are released 15 cells were transfected with a late endosome/MVB marker, GFP-tagged Rab7; stained with antibodies to HBV antigens, large HBV surface proteins, and HBV core protein; and then analyzed using confocal microscopy. 32 (B) TEM images of HepG2.2.15 cells show virus-like particles in MVBs. 32 (C) HCV-replicating cells that were treated with an MVB inhibitor, U18666A, were stained with 4′,6-diamidino-2-phenylindole, antibodies to HCV core, and an MVB/exosome marker, CD63. Confocal microscopic images show HCV accumulation in MVBs. The graph shows the intensities of 4′,6-diamidino-2-phenylindole, core, and CD63 along the white arrow. Republished with permission from an article. 30 (D) PLC/ PRF/5 cells that were infected with HEV were stained with antibodies to CD63, HEV ORF2 protein, and HEV ORF3 protein.
The cells were analyzed with confocal microscopy. (E) TEM images of HEV-infected cells show a virus-like particle in the MVB. Republished with permission from an article. 31 Abbreviations: Anti-HBc, antibody to HBV core antigen; Anti-LHBs, antibody to large HBV surface protein; DAPI, 4′,6-diamidino-2-phenylindole; GFP, green fluorescent protein.
by MVBs. 30 In that study, it was suggested that HCV particles are assembled in a membranous web of the ER that could be transported to an MVB compartment. Additionally, other reports have suggested that the ESCRT complex is associated with HCV release. 34 The details of how a transport pathway from the ER to MVBs might function are unclear, but the association of HCV particles with lipid droplets suggests that the viral particles might be transported in a way similar to lipoproteins. 30 In addition to HBV and HCV, it now appears that both HAV and HEV use the MVB pathways. For example, Feng et al. have recently suggested that HAV, when secreted into culture media and collected by centrifugation, consists of two populations of infectious particles that exhibit distinct morphologies of different buoyant density. 21 Light fraction particles are resistant to neutralization and are wrapped with cellular membranes, and only the enveloped HAV are found in the blood of patients with acute hepatitis A. Further, this study also suggested that HAV biogenesis depends on the ESCRT-associated proteins VPS4B and Alix. Two tandem YPX3L motifs are likely to associate with the Alix protein and, together with pX, direct the membrane envelopment of the capsid. Tyr-to-Ala substitutions within either motif impeded capsid assembly. From this finding it is difficult to determine whether the capsid interacts with Alix that binds this late domain motif. Depletion of VPS4B led to a significant reduction in enveloped HAV release. Therefore, it was supposed that HAV buds into MVBs.
In addition to the findings for HAV described above, HEV, which had been considered a virus lacking an envelope, uses ESCRT functions to form a limiting membrane that may help in the viral egress pathway. Specifically, the ORF3 protein possesses a PSAP motif that directs interactions with TSG101, a component of ESCRT-I, and disrupting this motif or depleting TSG101 results in a significant reduction in viral release. 35 Also, overexpression of a dominant-negative VPS4 mutant inhibits HEV release. Based on these results, it was suggested that ESCRT functions on MVBs are required for the egress of enveloped HEV.
Although the hepatitis viruses comprise envelope viruses (HBV, HCV, and HDV) and "noncanonically" enveloped viruses (HAV and HEV), recent studies reveal that not only HBV and HCV but also HAV and HEV use late endocytic compartments as an integral part of the maturation and release pathways. 21, 31, 35 Interestingly, the viral genomes of HAV and HEV do not encode for envelope proteins but instead appear to use pure cellular membranes derived from MVBs as envelope. A direct interaction between an envelope protein, large HBV surface protein, and core protein in HBV maturation has been predicted; and it is suggested that large HBV surface proteins is required for both efficient envelopment and cell entry. 36 As for noncanonically enveloped viruses, supportive viral proteins such as pX of HAV 21 and ORF3 protein of HEV 35 may aid in envelopment. Interestingly, the envelope derived from host lipid membrane without envelope protein may protect the virus from neutralizing antibodies. 21 Perhaps a central contribution of the MVB is the generation of ILVs that may act as exosome carriers to support the shedding of several types of viruses. The precise mechanisms by which MVBs might translocate to and fuse with the cell periphery remain unclear. This trafficking appears to be controlled in part by Rab protein as the small interfering RNA-mediated depletion of Rab2b, Rab5a, Rab9b, Rab27a, and Rab27b inhibits secretory release. 37, 38 One study has shown that Rab27a and Rab27b play different roles in the exosomal pathway as Rab27a may act in the docking/fusion of MVBs to the plasma membrane, while Rab27b participates in the transfer of MVBs from microtubules to the actinrich cortex and their retention at the cell periphery. The putative fusion of MVBs to the plasma membrane depends on soluble N-ethylmaleimide-sensitive factor attachment receptor proteins which regulate the fusion and target specificity in the general vesicle trafficking.
Despite our increased understanding of exosome biology and the consistent observations of the MVB pathway contributing to HBV maturation, the role of exosomes in HBV release remains undefined. The challenges that remain include, first, the difficulty in the purification of HBV particles from regular exosomes due to their similar size and density and, second, the excess of SVPs in the culture supernatant.
The use of the MVB pathway for the other hepatitis virus members is even less clear but possibly of equal importance. For example, HAV and HEV have been reported to use MVB functions, as mentioned earlier for HBV. 31 HAV is exported through either the apical membrane 39 or the basolateral membrane. Enveloped HAV that is released from the basolateral membrane results in the systemic circulation of virions, while those released from the apical membrane are shed in feces. The lack of an intact envelope may reflect the loss of membrane due to the detergent action of bile salts.
Recent findings revealed that exosomes from infected hepatocytes play a pivotal role in the activation of innate immunity for some viruses. Dreux et al. reported that exosomal transfer of the HCV genome from infected cells to plasmacytoid dendritic cells results in their activation. 40 A similar activation of plasmacytoid dendritic cells was observed by the uptake of enveloped HAV. 41 These important results suggest that the membrane trafficking machinery is used by the viral life cycle but also during antiviral host defense.
uSe oF tHe autopHagIC patHWay
The autophagic pathway is responsible for the degradative reuse of proteins, organelles, and damaged cellular components to generate energy substrates during nutrient deprivation. There are currently three types of autophagic processes: macroautophagy, chaperone-mediated autophagy, and microautophagy. Among these, because macroautophagy is the most characterized, we will refer to this as "autophagy." The autophagic pathway responds to signals from the environment and forms a double-membrane autophagic structure, or "autophagosome" that engulfs cytoplasmic organelles. As the autophagosome fuses with an acidic lysosome to become an autophagolysosome, the action of low pH-activated proteases degrades the autophagolysosome contents. This is a complicated process and requires well over 30 autophagy-related proteins that work in sequential coordination.
Interestingly, multiple pathogens including HBV and HCV are known to subvert this pathway for replication and/or survival. HCV infection induces autophagy, which has been reported to suppress the host immune response while amplifying HCV replication. 42 Further studies suggest that autophagy is required for viral protein translation to initiate infection 43 and while providing a membrane source for HCV replication complexes. Two reports have implicated the autophagic pathway in the HBV life cycle, suggesting that the autophagosome is required for DNA viral replication 44 and/or viral envelopment. 45 This requirement for DNA replication has recently been shown in vivo. Importantly, it appears that both the HBx protein 44 and the small HBV surface protein 45 are required for autophagic activation.
What function might the autophagic pathway provide in HBV propagation? It was shown that the late stages of autophagy were blocked by HBx, and assumed that impaired autophagy flux might be beneficial for HBV production. 46 A recent report showed that HBV infection activated adenosine monophosphate-activated protein kinase and promoted the autophagic degradation of HBV. 46 Canonical autophagy is viewed as a degradative process, but recently, the concept of secretory autophagy was proposed. 47 A range of cytoplasmic substrates including some viruses are believed to be exported through this pathway. 23, 31, 47 Additionally, an indirect association between autophagy and HBV was reported in which HBV-induced autophagy attenuates the immune response against HBV. While there appears to be a close association between autophagy and the HBV life cycle, the detailed mechanism of how HBV uses the autophagic pathway including secretory autophagy is still under investigation.
Conclusion
Viruses are well known to use the membrane trafficking machinery of the host cell, and the hepatitis viruses are no different. Despite significant inroads to defining how these host pathways are modified by invading pathogens, more basic investigation is required to define the interaction between the autophagic machinery and these viruses that will aid in the identification of novel therapeutic options to prevent and/or eliminate infection. Considering how these liver-centric viruses contribute to death and morbidity on a worldwide scale, support for research to identify novel therapies is urgently needed.
